IRIS Accounts Production v25.1.0.734 06386364 Board of Directors Board of Directors 1.4.24 31.3.25 31.3.25 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh063863642024-03-31063863642025-03-31063863642024-04-012025-03-31063863642023-03-31063863642023-04-012024-03-31063863642024-03-3106386364ns15:EnglandWales2024-04-012025-03-3106386364ns14:PoundSterling2024-04-012025-03-3106386364ns10:Director12024-04-012025-03-3106386364ns10:Director22024-04-012025-03-3106386364ns10:PrivateLimitedCompanyLtd2024-04-012025-03-3106386364ns10:SmallEntities2024-04-012025-03-3106386364ns10:AuditExempt-NoAccountantsReport2024-04-012025-03-3106386364ns10:SmallCompaniesRegimeForDirectorsReport2024-04-012025-03-3106386364ns10:SmallCompaniesRegimeForAccounts2024-04-012025-03-3106386364ns10:FullAccounts2024-04-012025-03-310638636412024-04-012025-03-3106386364ns10:RegisteredOffice2024-04-012025-03-3106386364ns5:CurrentFinancialInstruments2025-03-3106386364ns5:CurrentFinancialInstruments2024-03-3106386364ns5:Non-currentFinancialInstruments2025-03-3106386364ns5:Non-currentFinancialInstruments2024-03-3106386364ns5:ShareCapital2025-03-3106386364ns5:ShareCapital2024-03-3106386364ns5:SharePremium2025-03-3106386364ns5:SharePremium2024-03-3106386364ns5:RevaluationReserve2025-03-3106386364ns5:RevaluationReserve2024-03-3106386364ns5:CapitalRedemptionReserve2025-03-3106386364ns5:CapitalRedemptionReserve2024-03-3106386364ns5:RetainedEarningsAccumulatedLosses2025-03-3106386364ns5:RetainedEarningsAccumulatedLosses2024-03-3106386364ns5:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3106386364ns5:PatentsTrademarksLicencesConcessionsSimilar2024-04-012025-03-3106386364ns5:LongLeaseholdAssetsns5:LandBuildings2024-04-012025-03-3106386364ns5:PlantMachinery2024-04-012025-03-3106386364ns5:FurnitureFittings2024-04-012025-03-3106386364ns5:ComputerEquipment2024-04-012025-03-3106386364ns5:PatentsTrademarksLicencesConcessionsSimilar2024-03-3106386364ns5:PatentsTrademarksLicencesConcessionsSimilar2025-03-3106386364ns5:PatentsTrademarksLicencesConcessionsSimilar2024-03-3106386364ns5:LongLeaseholdAssetsns5:LandBuildings2024-03-3106386364ns5:PlantMachinery2024-03-3106386364ns5:FurnitureFittings2024-03-3106386364ns5:ComputerEquipment2024-03-3106386364ns5:LongLeaseholdAssetsns5:LandBuildings2025-03-3106386364ns5:PlantMachinery2025-03-3106386364ns5:FurnitureFittings2025-03-3106386364ns5:ComputerEquipment2025-03-3106386364ns5:LongLeaseholdAssetsns5:LandBuildings2024-03-3106386364ns5:PlantMachinery2024-03-3106386364ns5:FurnitureFittings2024-03-3106386364ns5:ComputerEquipment2024-03-3106386364ns5:CostValuation2024-03-3106386364ns5:RevaluationsIncreaseDecreaseInInvestments2025-03-3106386364ns5:CostValuation2025-03-3106386364ns5:BetweenOneTwoYearsns5:Non-currentFinancialInstruments2025-03-3106386364ns5:BetweenOneTwoYearsns5:Non-currentFinancialInstruments2024-03-3106386364ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2025-03-3106386364ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2024-03-3106386364ns5:RevaluationReserve2024-03-3106386364ns5:RevaluationReserve2024-04-012025-03-3106386364ns10:Director222024-03-3106386364ns10:Director222023-03-3106386364ns10:Director222024-04-012025-03-3106386364ns10:Director222023-04-012024-03-3106386364ns10:Director222025-03-3106386364ns10:Director222024-03-31
REGISTERED NUMBER: 06386364 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025

FOR

MORTGAGE MEDICS LIMITED

MORTGAGE MEDICS LIMITED (REGISTERED NUMBER: 06386364)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


MORTGAGE MEDICS LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MARCH 2025







DIRECTORS: J Bloomfield
S A Murphy





REGISTERED OFFICE: 353A Portland Road
Hove
East Sussex
BN3 5SF





REGISTERED NUMBER: 06386364 (England and Wales)





ACCOUNTANTS: Galloways Accounting (Hove) Limited
15 West Street
Brighton
East Sussex
BN1 2RL

MORTGAGE MEDICS LIMITED (REGISTERED NUMBER: 06386364)

BALANCE SHEET
31 MARCH 2025

2025 2024
Notes £    £    £   
FIXED ASSETS
Intangible assets 3 3,790 3,450
Tangible assets 4 27,187 36,416
Investments 5 54,694 54,430
85,671 94,296

CURRENT ASSETS
Cash at bank and in hand 177,916 139,336

CREDITORS
Amounts falling due within one year 6 80,413 62,574
NET CURRENT ASSETS 97,503 76,762
TOTAL ASSETS LESS CURRENT
LIABILITIES

183,174

171,058

CREDITORS
Amounts falling due after more than one
year

7

(1,667

)

(11,667

)

PROVISIONS FOR LIABILITIES (2,878 ) (3,579 )
NET ASSETS 178,629 155,812

CAPITAL AND RESERVES
Called up share capital 100 101
Share premium 49 49
Revaluation reserve 8 4,694 4,430
Capital redemption reserve (2,999 ) -
Retained earnings 176,785 151,232
178,629 155,812

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

MORTGAGE MEDICS LIMITED (REGISTERED NUMBER: 06386364)

BALANCE SHEET - continued
31 MARCH 2025


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 25 April 2025 and were signed on its behalf by:




J Bloomfield - Director



S A Murphy - Director


MORTGAGE MEDICS LIMITED (REGISTERED NUMBER: 06386364)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025


1. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Turnover
Turnover represents sales of services and is recognised at the point the customer is entitled to consideration.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Patents and licences are being amortised evenly over their estimated useful life of nil years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Long leasehold - 10% on cost
Plant and machinery - 25% on cost
Fixtures and fittings - 33% on cost
Computer equipment - 33% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

2. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 11 (2024 - 15 ) .

MORTGAGE MEDICS LIMITED (REGISTERED NUMBER: 06386364)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025


3. INTANGIBLE FIXED ASSETS
Patents
and
licences
£   
COST
At 1 April 2024 3,450
Additions 340
At 31 March 2025 3,790
NET BOOK VALUE
At 31 March 2025 3,790
At 31 March 2024 3,450

4. TANGIBLE FIXED ASSETS
Fixtures
Long Plant and and Computer
leasehold machinery fittings equipment Totals
£    £    £    £    £   
COST
At 1 April 2024 91,282 3,395 55,401 31,617 181,695
Additions 3,000 - - 433 3,433
Disposals - - (3,620 ) - (3,620 )
At 31 March 2025 94,282 3,395 51,781 32,050 181,508
DEPRECIATION
At 1 April 2024 62,335 2,547 50,177 30,220 145,279
Charge for year 9,239 848 1,863 712 12,662
Eliminated on disposal - - (3,620 ) - (3,620 )
At 31 March 2025 71,574 3,395 48,420 30,932 154,321
NET BOOK VALUE
At 31 March 2025 22,708 - 3,361 1,118 27,187
At 31 March 2024 28,947 848 5,224 1,397 36,416

5. FIXED ASSET INVESTMENTS
Other
investments
£   
COST OR VALUATION
At 1 April 2024 54,430
Revaluations 264
At 31 March 2025 54,694
NET BOOK VALUE
At 31 March 2025 54,694
At 31 March 2024 54,430

MORTGAGE MEDICS LIMITED (REGISTERED NUMBER: 06386364)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025


5. FIXED ASSET INVESTMENTS - continued

Cost or valuation at 31 March 2025 is represented by:

Other
investments
£   
Valuation in 2024 4,162
Valuation in 2025 264
Cost 50,268
54,694

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Bank loans and overdrafts 10,000 10,000
Tax 44,113 23,817
Social security and other taxes 13,790 13,448
Other creditors 8,012 8,428
Directors' loan accounts 599 2,919
Accrued expenses 3,899 3,962
80,413 62,574

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
2025 2024
£    £   
Bank loans - 1-2 years 1,667 10,000
Bank loans - 2-5 years - 1,667
1,667 11,667

8. RESERVES
Revaluation
reserve
£   
At 1 April 2024 4,430
Bonus share issue 264

At 31 March 2025 4,694

9. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 March 2025 and 31 March 2024:

2025 2024
£    £   
S A Murphy
Balance outstanding at start of year (1,198 ) (599 )
Amounts advanced 1,198 -
Amounts repaid (599 ) (599 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (599 ) (1,198 )

MORTGAGE MEDICS LIMITED (REGISTERED NUMBER: 06386364)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025


9. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES - continued

This balance represented the maximum amount outstanding during the year and the loan is interest free and repayable on demand.

10. ULTIMATE CONTROLLING PARTY

The controlling party is S A Murphy.

This was by virtue of his 90% holding of the issued share capital.